GlaxoSmithKline PLC Board and Committee Changes (8440X)
May 06 2021 - 12:51PM
UK Regulatory
TIDMGSK
RNS Number : 8440X
GlaxoSmithKline PLC
06 May 2021
GlaxoSmithKline plc
GSK announces changes to its Board and Committees
GlaxoSmithKline plc today announces the following changes to its
Board and Committee membership effective 6 May 2021.
As previously announced, Dr Anne Beal has joined the Board as an
Independent Non-Executive Director. She has been appointed a member
of the Corporate Responsibility Committee.
In addition, Charles Bancroft has been appointed a member of the
Nominations & Corporate Governance and Science Committees.
These appointments are in addition to his role as Chairman of the
Audit & Risk Committee and membership of the Transformation
& Separation Committee.
Note
1. From 6 May 2021 the Board of GSK comprises
Sir Jonathan Symonds Non-Executive Chairman
Emma Walmsley Chief Executive Officer
Iain Mackay Chief Financial Officer
Dr Hal Barron Chief Scientific Officer and President,
Vindi Banga R&D
Charles Bancroft Senior Independent Non-Executive Director
Dr Anne Beal Independent Non-Executive Director
Dr Vivienne Cox Independent Non-Executive Director
Lynn Elsenhans Independent Non-Executive Director
Dr Jesse Goodman Independent Non-Executive Director
Dr Laurie Glimcher Independent Non-Executive Director
Urs Rohner Independent Non-Executive Director
Independent Non-Executive Director
V A Whyte
Company Secretary
6 May 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABLGDUCSGDGBL
(END) Dow Jones Newswires
May 06, 2021 12:51 ET (16:51 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024